Condition
Ssri
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Unknown2
Clinical Trials (2)
Showing 2 of 2 trials
NCT05646693Phase 2Unknown
Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus
NCT02753738Phase 4UnknownPrimary
Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake Inhibitors
Showing all 2 trials